WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 31, 2007, 27(5):1211-1219; doi:10.1523/JNEUROSCI.4159-06.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimotodani, Y.
Right arrow Articles by Kano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimotodani, Y.
Right arrow Articles by Kano, M.

 Previous Article  |  Next Article 

Cellular/Molecular
Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus

Yuki Hashimotodani,1 Takako Ohno-Shosaku,3 and Masanobu Kano2

1Departments of Neurophysiology and 2Cellular Neuroscience, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan, and 3Department of Impairment Study, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-0942, Japan

Correspondence should be addressed to Masanobu Kano, Department of Cellular Neuroscience, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan. Email: mkano{at}cns.med.osaka-u.ac.jp

Endocannabinoids function as retrograde messengers and modulate synaptic transmission through presynaptic cannabinoid CB1 receptors. The magnitude and time course of endocannabinoid signaling are thought to depend on the balance between the production and degradation of endocannabinoids. The major endocannabinoid 2-arachidonoylglycerol (2-AG) is hydrolyzed by monoacylglycerol lipase (MGL), which is shown to be localized at axon terminals. In the present study, we investigated how MGL regulates endocannabinoid signaling and influences synaptic transmission in the hippocampus. We found that MGL inhibitors, methyl arachidonoyl fluorophosphonate and arachidonoyl trifluoromethylketone, caused a gradual suppression of cannabinoid-sensitive IPSCs in cultured hippocampal neurons. This suppression was reversed by blocking CB1 receptors and was attenuated by inhibiting 2-AG synthesis, indicating that MGL scavenges constitutively released 2-AG. We also found that the MGL inhibitors significantly prolonged the suppression of both IPSCs and EPSCs induced by exogenous 2-AG and depolarization-induced suppression of inhibition/excitation, a phenomenon known to be mediated by retrograde endocannabinoid signaling. In contrast, inhibitors of other endocannabinoid hydrolyzing enzymes, fatty acid amide hydrolase and cyclooxygenase-2, had no effect on the 2-AG-induced IPSC suppression. These results strongly suggest that presynaptic MGL not only hydrolyzes 2-AG released from activated postsynaptic neurons but also contributes to degradation of constitutively produced 2-AG and prevention of its accumulation around presynaptic terminals. Thus, the MGL activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus.

Key words: 2-arachidonoylglycerol; monoacylglycerol lipase; diacylglycerol lipase; CB1 cannabinoid receptor; depolarization-induced suppression of inhibition; hippocampus


Received Sept. 22, 2006; revised Dec. 5, 2006; accepted Dec. 15, 2006.

Correspondence should be addressed to Masanobu Kano, Department of Cellular Neuroscience, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan. Email: mkano{at}cns.med.osaka-u.ac.jp




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. Pan, W. Wang, J. Z. Long, D. Sun, C. J. Hillard, B. F. Cravatt, and Q.-s. Liu
Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. A. Mitchell, H. Kawahara, and C. W. Vaughan
Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey
J. Physiol., June 1, 2009; 587(11): 2511 - 2520.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. Zhao, M. E. Rubio, and T. Tzounopoulos
Distinct Functional and Anatomical Architecture of the Endocannabinoid System in the Auditory Brainstem
J Neurophysiol, May 1, 2009; 101(5): 2434 - 2446.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev, January 1, 2009; 89(1): 309 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Marinelli, S. Pacioni, T. Bisogno, V. Di Marzo, D. A. Prince, J. R. Huguenard, and A. Bacci
The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
J. Neurosci., December 10, 2008; 28(50): 13532 - 13541.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. K. Lau and C. W. Vaughan
Muscarinic Modulation of Synaptic Transmission via Endocannabinoid Signalling in the Rat Midbrain Periaqueductal Gray
Mol. Pharmacol., November 1, 2008; 74(5): 1392 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. M. Eggan, T. Hashimoto, and D. A. Lewis
Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Arch Gen Psychiatry, July 1, 2008; 65(7): 772 - 784.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nyilas, B. Dudok, G. M. Urban, K. Mackie, M. Watanabe, B. F. Cravatt, T. F. Freund, and I. Katona
Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals
J. Neurosci., January 30, 2008; 28(5): 1058 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Hashimotodani, T. Ohno-Shosaku, M. Watanabe, and M. Kano
Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release
J. Physiol., October 15, 2007; 584(2): 373 - 380.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Ohno-Shosaku, Y. Hashimotodani, M. Ano, S. Takeda, H. Tsubokawa, and M. Kano
Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons
J. Physiol., October 15, 2007; 584(2): 407 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. K. Makara, I. Katona, G. Nyiri, B. Nemeth, C. Ledent, M. Watanabe, J. de Vente, T. F. Freund, and N. Hajos
Involvement of Nitric Oxide in Depolarization-Induced Suppression of Inhibition in Hippocampal Pyramidal Cells during Activation of Cholinergic Receptors
J. Neurosci., September 19, 2007; 27(38): 10211 - 10222.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-